BRIDGEWAY CAPITAL MANAGEMENT, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 89 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$2,474,491
+14.4%
437,963
-16.8%
0.06%
+31.8%
Q1 2024$2,163,434
+41.9%
526,383
+45.7%
0.04%
+33.3%
Q4 2023$1,524,129
-44.3%
361,168
-43.0%
0.03%
-50.0%
Q3 2023$2,734,901
-43.5%
633,079
-13.8%
0.07%
-43.1%
Q2 2023$4,837,554
+3.5%
734,075
+6.6%
0.12%
-6.5%
Q1 2023$4,673,808
+94.2%
688,337
+111.4%
0.12%
+100.0%
Q4 2022$2,406,184
-4.3%
325,600
+103.1%
0.06%
+31.9%
Q4 2021$2,515,000
+2.9%
160,300
+12.4%
0.05%0.0%
Q3 2021$2,444,000
-20.3%
142,6000.0%0.05%
-14.5%
Q2 2021$3,067,000
+427.0%
142,600
+307.4%
0.06%
+511.1%
Q3 2016$582,000
+48.5%
35,0000.0%0.01%
+50.0%
Q2 2016$392,000
+33.8%
35,0000.0%0.01%
+20.0%
Q1 2016$293,000
-46.9%
35,000
-41.0%
0.01%
-50.0%
Q4 2015$552,000
-17.5%
59,3000.0%0.01%
-28.6%
Q3 2015$669,000
-11.2%
59,3000.0%0.01%
-6.7%
Q2 2015$753,000
+2.2%
59,300
-25.2%
0.02%0.0%
Q1 2015$737,000
-35.7%
79,300
-0.9%
0.02%
-42.3%
Q4 2014$1,146,000
+38.1%
80,0000.0%0.03%
+23.8%
Q3 2014$830,000
-35.9%
80,0000.0%0.02%
-38.2%
Q2 2014$1,294,000
-62.9%
80,000
-62.8%
0.03%
-66.0%
Q1 2014$3,490,000
+13.3%
214,792
-13.4%
0.10%
+6.4%
Q4 2013$3,079,000
+13.3%
248,1000.0%0.09%
+1.1%
Q3 2013$2,717,000
+35.0%
248,100
-0.4%
0.09%
+16.2%
Q2 2013$2,013,000249,1000.08%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders